{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:48:25Z","timestamp":1790462905753,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11096-021-01263-w","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T03:27:38Z","timestamp":1619321258000},"page":"441-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-4909","authenticated-orcid":false,"given":"Olaf","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Happe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Huchtemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ohms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Erzkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"1263_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1071\/AH18251","volume":"44","author":"V Hsieh","year":"2020","unstructured":"Hsieh V, Paull G, Hawkshaw B. Heart Failure Integrated Care Project: overcoming barriers encountered by primary health care providers in heart failure management. Aust Health Rev. 2020;44:451\u20138.","journal-title":"Aust Health Rev"},{"key":"1263_CR2","unstructured":"Community-based care for the specialized management of heart failure: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9:1\u201342."},{"key":"1263_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/1468-0009.12416","volume":"97","author":"EH Wagner","year":"2019","unstructured":"Wagner EH. Organizing care for patients with chronic illness revisited. Milbank Q. 2019;97:659\u201364.","journal-title":"Milbank Q"},{"key":"1263_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(20)30064-8","volume":"19","author":"BR Bloem","year":"2020","unstructured":"Bloem BR, Henderson EJ, Dorsey ER, Okun MS, Okubadejo N, Chan P, et al. Integrated and patient-centred management of Parkinson\u2019s disease: a network model for reshaping chronic neurological care. Lancet Neurol. 2020;19:623\u201334.","journal-title":"Lancet Neurol"},{"key":"1263_CR5","doi-asserted-by":"crossref","unstructured":"Bloem BR, Rompen L, Vries NMd, Klink A, Munneke M, Jeurissen P. ParkinsonNet: A Low-Cost Health Care Innovation With A Systems Approach From The Netherlands. Health Aff (Millwood). 2017;36:1987\u201396.","DOI":"10.1377\/hlthaff.2017.0832"},{"key":"1263_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s11096-012-9672-9","volume":"34","author":"S Schr\u00f6der","year":"2012","unstructured":"Schr\u00f6der S, Martus P, Odin P, Schaefer M. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson\u2019s disease. Int J Clin Pharm. 2012;34:746\u201356.","journal-title":"Int J Clin Pharm"},{"key":"1263_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11096-015-0206-0","volume":"38","author":"M Henrichsmann","year":"2016","unstructured":"Henrichsmann M, Hempel G. Impact of medication therapy management in patients with Parkinson\u2019s disease. Int J Clin Pharm. 2016;38:54\u201360.","journal-title":"Int J Clin Pharm"},{"key":"1263_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.sapharm.2019.11.002","volume":"16","author":"TL Imfeld-Isenegger","year":"2020","unstructured":"Imfeld-Isenegger TL, Soares IB, Makovec UN, Horvat N, Kos M, van Mil F, et al. Community pharmacist-led medication review procedures across Europe: characterization, implementation and remuneration. Res Soc Adm Pharm. 2020;16:1057\u201366.","journal-title":"Res Soc Adm Pharm"},{"key":"1263_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.5414\/CP203264","volume":"56","author":"O Rose","year":"2018","unstructured":"Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, et al. Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen. Int J Clin Pharmacol Ther. 2018;56:518\u201330.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1263_CR10","doi-asserted-by":"publisher","first-page":"16856","DOI":"10.1038\/s41598-019-53057-w","volume":"9","author":"M Stuhec","year":"2019","unstructured":"Stuhec M, Bratovi\u0107 N, Mrhar A. Impact of clinical pharmacist\u2019s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study. Sci Rep. 2019;9:16856.","journal-title":"Sci Rep"},{"key":"1263_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12913-019-3942-3","volume":"19","author":"M Stuhec","year":"2019","unstructured":"Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res. 2019;19:118.","journal-title":"BMC Health Serv Res"},{"key":"1263_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"issue":"9","key":"1263_CR13","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/jcm9072272","volume":"17","author":"L Kerkemeyer","year":"2020","unstructured":"Kerkemeyer L, Achtert K, Claus I, Happe S, Overbeck J, Kleen N, et al. Quickcard-based approach to guiding specific nonpharmacological treatments in a German Parkinson\u2018s network. J Clin Med. 2020;17(9):2272.","journal-title":"J Clin Med"},{"key":"1263_CR14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00103-018-2789-9","volume":"61","author":"H Dormann","year":"2018","unstructured":"Dormann H, Maas R, Eickhoff C, M\u00fcller U, Schulz M, Brell D, et al. Standardized national medication plan\u202f: the pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:1093\u2013102.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1263_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1715163514529740","volume":"147","author":"T Patel","year":"2014","unstructured":"Patel T, Chang F. Parkinson\u2019s disease guidelines for pharmacists. Can Pharm J (Ott). 2014;147:161\u201370.","journal-title":"Can Pharm J (Ott)"},{"key":"1263_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/JNN.0000000000000472","volume":"51","author":"H Azmi","year":"2019","unstructured":"Azmi H, Cocoziello L, Harvey R, McGee M, Desai N, Thomas J, et al. Development of a Joint Commission Disease-Specific Care Certification Program for Parkinson Disease in an Acute Care Hospital. J Neurosci Nurs. 2019;51:313\u20139.","journal-title":"J Neurosci Nurs"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-021-01263-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-021-01263-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T15:14:11Z","timestamp":1624115651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-021-01263-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s11096-021-01263-w","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Susanne Erzkamp has received a speaker honorarium from MSD Sharp & Dohme, Svenja Happe has received lecturer honoraria from Bial, Bioprojet and Bayer Vital, Tessa Huchtemann declares that she has no competing interests, Constanze M\u00f6nig declares that she has no competing interests, Michael Ohms declares that he has no competing interests, Oliver Schwalbe declares that he has no competing interests, Olaf Rose has received a speaker honorarium from AbbVie, MSD Sharp & Dohme, Novartis and Omnicell, Tobias Warnecke has received lecturer and consulting honoraria from AbbVie, UCB Pharma, Archimedes, Bayer, Bial, Biogen, Desitin, Licher, Phagenesis, Pfizer, Teva, and Zambon.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was not obtained as no patient data was used in this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"was not obtained as no patient data were used in this publication","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}